Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MESA LABORATORIES INC /CO/ Director's Dealing 2022

Sep 2, 2022

33153_dirs_2022-09-02_eedc8060-12f5-4979-97c9-5bec68383d13.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MESA LABORATORIES INC /CO/ (MLAB)
CIK: 0000724004
Period of Report: 2022-09-01

Reporting Person: Sakys John (CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-09-01 Common Stock M 1303 Acquired 9981 Direct
2022-09-01 Common Stock M 514 Acquired 10495 Direct
2022-09-01 Common Stock F 799 $178.42 Disposed 9696 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-09-01 Restricted Stock Units - 4 $ M 1303 Disposed Common Stock (1303) Direct
2022-09-01 Restricted Stock Units - 3 $ M 514 Disposed Common Stock (514) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 100 Indirect

Footnotes

F1: Each RSU represents a contingent right to receive one share of the Issuer's common stock

F2: RSUs that vested on September 1, 2022

F3: Not applicable

F4: RSUs that vest 1/3 on September 1, 2022, 1/3 on June 15, 2023 and 1/3 on June 15, 2024

F5: 100 shares held by children of which Mr. Sakys is custodian